ARK 每周股评 – 4/15/2022


We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

Nurix Therapeutics (NRIX)
-16%Shares of Nurix Therapeutics fell 16% on Monday after rising 6.2% the prior week on positive earnings for the first quarter and news of early compelling data from its clinical trials for the drug-enhanced tumor-infiltrating lymphocyte, DeTIL-0255. Nurix is a leading therapeutics company in the emerging targeted protein therapeutics (TPD) space.

注: Nurix Therapeutics公司的股价在周一下跌了16%,此前一周该公司因第一季度的积极收益和其药物增强型肿瘤浸润淋巴细胞DeTIL-0255的临床试验的早期引人注目的数据消息而上涨了6.2%。Nurix是新兴的靶向蛋白疗法(TPD)领域的一家领先治疗公司。
Kaspi (KSPI)
+17%Shares of Kaspi rose 17% on Tuesday as Kazakh authorities met with US counterparts to discuss minimizing the impact of Kazakhstan-specific Russia sanctions. Kaspi, the largest digital wallet in Kazakhstan, provides payment and lending products for more than half the Kazakh population.

注: 周二,Kaspi的股票上涨了17%,因为哈萨克斯坦当局与美国同行会面,讨论如何将针对哈萨克斯坦的俄罗斯制裁的影响降到最低。Kaspi是哈萨克斯坦最大的数字钱包,为超过一半的哈萨克斯坦人口提供支付和贷款产品。
Burning Rock Biotech (BNR)
-15%Shares of Burning Rock Biotech fell 15% on Thursday during a volatile day for biotech and Chinese stocks. Burning Rock is a Chinese next generation sequencing company focused on precision oncology.

注: 周四,在生物技术和中国股票波动的日子里,燃石医学的股票下跌了15%。燃石医学是一家专注于精准肿瘤学的中国下一代测序公司。
Zymergen (ZY)
-15%Shares of Zymergen dropped 15% on Thursday, continuing their slide since the company’s leadership change and restructuring under Jay Flatley, former CEO of Illumina, last August. Zymergen is a synthetic biology company focused on developing valuable chemical and biological products with industrial-scale fermentation methods.

注: Zymergen公司的股票周四下跌了15%,自去年8月该公司在Illumina公司前首席执行官Jay Flatley的带领下进行领导层变动和重组以来继续下滑。Zymergen是一家合成生物学公司,专注于用工业规模的发酵方法开发有价值的化学和生物产品。


上一篇 2022年4月15日 上午8:45
下一篇 2022年4月19日 下午3:49



您的电子邮箱地址不会被公开。 必填项已用*标注